Vincamine, a safe natural alkaloid, represents a novel anticancer agent

Area of Science:

• Pharmacology
• Cell Biology
• Biochemistry

Background:

• Vincamine, a plant alkaloid, is recognized for its use as a dietary supplement and vasodilator.
• Its potential as an anticancer agent has not been previously investigated.

Purpose of the Study:

• To investigate the anticancer effects of vincamine on human alveolar basal epithelial cells (A549).
• To elucidate the molecular mechanisms underlying vincamine's anti-proliferative activity.

Main Methods:

• In vitro assays were used to assess cell viability, reactive oxygen species (ROS) generation, nuclear condensation, caspase-3 activity, and mitochondrial membrane potential (ΔΨm).
• In silico studies were performed to predict the interaction between vincamine and caspase-3.
• Cytotoxicity was evaluated in non-cancerous cell lines (BEAS-2B and 3T3-L1).

Main Results:

• Vincamine demonstrated significant anti-proliferative effects on A549 cells with an IC50 of 309.7 μM.
• Molecular assays indicated that vincamine induces apoptosis by stimulating caspase-3 activity, lowering mitochondrial membrane potential, and promoting cytochrome C release.
• In silico analysis revealed a high binding affinity between vincamine and caspase-3.
• Vincamine effectively quenched hydroxyl free radicals and depleted iron ions within cancer cells.
• Vincamine exhibited low toxicity in non-cancerous BEAS-2B and 3T3-L1 cells.

Conclusions:

• Vincamine possesses anticancer properties against human lung cancer cells (A549) through caspase-3-dependent apoptosis.
• Vincamine's ability to modulate ROS and iron levels contributes to its anticancer effects.
• Vincamine represents a potentially safe therapeutic agent for lung cancer, warranting further investigation in other cancer types.